AF
GYRE icon

Allworth Financial’s Gyre Therapeutics GYRE Stock Holding History

Allworth Financial’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251 Sell
38
-683
-95% -$4.65K ﹤0.01% 4928
2026
Q1 		$5.03K Buy
+721
New +$5.6K ﹤0.01% 3957

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Allworth Financial's GYRE Position: Q2 2026 in Review

Allworth Financial reduced its Gyre Therapeutics (GYRE) stake by 95% in Q2 2026, selling an estimated $4.65K and leaving 38 shares worth $251. The position accounts for ﹤0.01% of the portfolio, ranked #4928.

Allworth Financial first reported a position in GYRE in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.03K in Q1 2026. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Allworth Financial held 38 shares of Gyre Therapeutics worth $251 as of Q2 2026.
  • Allworth Financial sold 683 Gyre Therapeutics shares in Q2 2026, an estimated $4.65K.
  • Gyre Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4928 holding.
  • Allworth Financial first reported a position in Gyre Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Allworth Financial's Gyre Therapeutics position peaked at $5.03K in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.